Immunotherapy via dendritic cells

A. Karolina Palucka, Beatrice Laupeze, Caroline Aspord, Hiroaki Saito, Gaetan Jego, Joseph Fay, Sophie Paczesny, Virginia Pascual, Jacques Banchereau

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The immune system evolved to protect us from microbes. The antigen (Ag)-nonspecific innate immunity and Ag-specific adaptive immunity synergize to eradicate the invading pathogen through cells, such as dendritic cells (DCZ7) and lymphocytes, and through their effector proteins including antimicrobial peptides, complement, and antibodies. Its intrinsic complexity renders the immune system prone to dysfunction including cancer, autoimmunity, chronic inflammation and allergy. DCs are unique in their capacity to induce and regulate immune responses and are therefore attractive candidates for immunotherapy. However, DCs consist of distinct subsets with common as well as unique functions that lead to distinct types of immune responses. Therefore, understanding DC heterogeneity and their role in immunopathology is critical to design better strategies for immunotherapy. Indeed, what we learn from studying autoimmunity will help us induce strong vaccine specific immunity, either protective, as in the case of microbes, or therapeutic, as in the case of tumors.

Original languageEnglish (US)
Pages (from-to)105-114
Number of pages10
JournalAdvances in Experimental Medicine and Biology
Volume560
StatePublished - Dec 1 2005

Fingerprint

Immune system
Autoimmunity
Immunotherapy
Dendritic Cells
Immune System
Allergies
Antigens
Lymphocytes
Adaptive Immunity
Pathogens
Set theory
Innate Immunity
Tumors
Immunity
Neoplasms
Hypersensitivity
Vaccines
Inflammation
Peptides
Antibodies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Palucka, A. K., Laupeze, B., Aspord, C., Saito, H., Jego, G., Fay, J., ... Banchereau, J. (2005). Immunotherapy via dendritic cells. Advances in Experimental Medicine and Biology, 560, 105-114.

Immunotherapy via dendritic cells. / Palucka, A. Karolina; Laupeze, Beatrice; Aspord, Caroline; Saito, Hiroaki; Jego, Gaetan; Fay, Joseph; Paczesny, Sophie; Pascual, Virginia; Banchereau, Jacques.

In: Advances in Experimental Medicine and Biology, Vol. 560, 01.12.2005, p. 105-114.

Research output: Contribution to journalArticle

Palucka, AK, Laupeze, B, Aspord, C, Saito, H, Jego, G, Fay, J, Paczesny, S, Pascual, V & Banchereau, J 2005, 'Immunotherapy via dendritic cells', Advances in Experimental Medicine and Biology, vol. 560, pp. 105-114.
Palucka AK, Laupeze B, Aspord C, Saito H, Jego G, Fay J et al. Immunotherapy via dendritic cells. Advances in Experimental Medicine and Biology. 2005 Dec 1;560:105-114.
Palucka, A. Karolina ; Laupeze, Beatrice ; Aspord, Caroline ; Saito, Hiroaki ; Jego, Gaetan ; Fay, Joseph ; Paczesny, Sophie ; Pascual, Virginia ; Banchereau, Jacques. / Immunotherapy via dendritic cells. In: Advances in Experimental Medicine and Biology. 2005 ; Vol. 560. pp. 105-114.
@article{0fece927c0594740b7a2d87f0a6b8a4f,
title = "Immunotherapy via dendritic cells",
abstract = "The immune system evolved to protect us from microbes. The antigen (Ag)-nonspecific innate immunity and Ag-specific adaptive immunity synergize to eradicate the invading pathogen through cells, such as dendritic cells (DCZ7) and lymphocytes, and through their effector proteins including antimicrobial peptides, complement, and antibodies. Its intrinsic complexity renders the immune system prone to dysfunction including cancer, autoimmunity, chronic inflammation and allergy. DCs are unique in their capacity to induce and regulate immune responses and are therefore attractive candidates for immunotherapy. However, DCs consist of distinct subsets with common as well as unique functions that lead to distinct types of immune responses. Therefore, understanding DC heterogeneity and their role in immunopathology is critical to design better strategies for immunotherapy. Indeed, what we learn from studying autoimmunity will help us induce strong vaccine specific immunity, either protective, as in the case of microbes, or therapeutic, as in the case of tumors.",
author = "Palucka, {A. Karolina} and Beatrice Laupeze and Caroline Aspord and Hiroaki Saito and Gaetan Jego and Joseph Fay and Sophie Paczesny and Virginia Pascual and Jacques Banchereau",
year = "2005",
month = "12",
day = "1",
language = "English (US)",
volume = "560",
pages = "105--114",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Immunotherapy via dendritic cells

AU - Palucka, A. Karolina

AU - Laupeze, Beatrice

AU - Aspord, Caroline

AU - Saito, Hiroaki

AU - Jego, Gaetan

AU - Fay, Joseph

AU - Paczesny, Sophie

AU - Pascual, Virginia

AU - Banchereau, Jacques

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The immune system evolved to protect us from microbes. The antigen (Ag)-nonspecific innate immunity and Ag-specific adaptive immunity synergize to eradicate the invading pathogen through cells, such as dendritic cells (DCZ7) and lymphocytes, and through their effector proteins including antimicrobial peptides, complement, and antibodies. Its intrinsic complexity renders the immune system prone to dysfunction including cancer, autoimmunity, chronic inflammation and allergy. DCs are unique in their capacity to induce and regulate immune responses and are therefore attractive candidates for immunotherapy. However, DCs consist of distinct subsets with common as well as unique functions that lead to distinct types of immune responses. Therefore, understanding DC heterogeneity and their role in immunopathology is critical to design better strategies for immunotherapy. Indeed, what we learn from studying autoimmunity will help us induce strong vaccine specific immunity, either protective, as in the case of microbes, or therapeutic, as in the case of tumors.

AB - The immune system evolved to protect us from microbes. The antigen (Ag)-nonspecific innate immunity and Ag-specific adaptive immunity synergize to eradicate the invading pathogen through cells, such as dendritic cells (DCZ7) and lymphocytes, and through their effector proteins including antimicrobial peptides, complement, and antibodies. Its intrinsic complexity renders the immune system prone to dysfunction including cancer, autoimmunity, chronic inflammation and allergy. DCs are unique in their capacity to induce and regulate immune responses and are therefore attractive candidates for immunotherapy. However, DCs consist of distinct subsets with common as well as unique functions that lead to distinct types of immune responses. Therefore, understanding DC heterogeneity and their role in immunopathology is critical to design better strategies for immunotherapy. Indeed, what we learn from studying autoimmunity will help us induce strong vaccine specific immunity, either protective, as in the case of microbes, or therapeutic, as in the case of tumors.

UR - http://www.scopus.com/inward/record.url?scp=20344401113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344401113&partnerID=8YFLogxK

M3 - Article

C2 - 15932026

AN - SCOPUS:20344401113

VL - 560

SP - 105

EP - 114

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -